PGA
Portland Global Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $251K | Hold |
33,185
| – | – | 0.03% | 128 |
|
|
2025
Q1 | $183K | Hold |
33,185
| – | – | 0.02% | 130 |
|
|
2024
Q4 | $191K | Hold |
33,185
| – | – | 0.02% | 134 |
|
|
2024
Q3 | $344K | Hold |
33,185
| – | – | 0.04% | 110 |
|
|
2024
Q2 | $430K | Buy |
33,185
+8,810
| +36% | +$114K | 0.06% | 100 |
|
|
2024
Q1 | $426K | Sell |
24,375
-9,800
| -29% | -$171K | 0.06% | 102 |
|
|
2023
Q4 | $322K | Hold |
34,175
| – | – | 0.05% | 102 |
|
|
2023
Q3 | $382K | Hold |
34,175
| – | – | 0.06% | 96 |
|
|
2023
Q2 | $731K | Hold |
34,175
| – | – | 0.12% | 78 |
|
|
2023
Q1 | $1.38M | Sell |
34,175
-2,030
| -6% | -$82.1K | 0.24% | 68 |
|
|
2022
Q4 | $1.68M | Hold |
36,205
| – | – | 0.31% | 63 |
|
|
2022
Q3 | $1.88M | Sell |
36,205
-11,905
| -25% | -$618K | 0.38% | 57 |
|
|
2022
Q2 | $2.27M | Sell |
48,110
-5,250
| -10% | -$248K | 0.44% | 54 |
|
|
2022
Q1 | $3.8M | Sell |
53,360
-22,509
| -30% | -$1.6M | 0.65% | 43 |
|
|
2021
Q4 | $5.67M | Buy |
75,869
+13,234
| +21% | +$990K | 0.95% | 31 |
|
|
2021
Q3 | $3.56M | Buy |
+62,635
| New | +$3.56M | 0.66% | 41 |
|